Antiarrhythmic Medications in Patients with Adult Congenital Heart Disease

Rawan Amir1, Jenna A Milstein1, Konstantinos N Aronis2

  • 1Division of Cardiology, Johns Hopkins Hospital, Sheikh Zayed Tower 7120, 1800 Orleans Street, Baltimore, MD 21287, USA.

PubMed

Insights

Anti-arrhythmic drugs (AADs) are crucial for managing arrhythmias in adults with congenital heart disease (ACHD). This review offers guidance on AAD selection tailored to specific ACHD conditions and patient physiology.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Adult Congenital Heart Disease

Background:

  • Arrhythmias significantly impact morbidity and mortality in the growing adult congenital heart disease (ACHD) population.
  • Anti-arrhythmic drugs (AADs) remain vital for managing arrhythmias in ACHD patients, despite advancements in catheter ablation.
  • Current guidance on AAD use in the diverse ACHD population is limited.

Purpose of the Study:

  • To provide a comprehensive overview of arrhythmias in various ACHD conditions.
  • To discuss physiological considerations relevant to AAD use in ACHD.
  • To outline strategies for selecting AADs tailored to specific ACHD patient profiles.

Main Methods:

  • Literature review of arrhythmias in ACHD.
  • Analysis of physiological factors influencing AAD efficacy and safety in ACHD.
  • Pharmacological profile of commonly used AADs.

Main Results:

  • Detailed overview of common arrhythmias across different ACHD diagnoses.
  • Identification of key physiological factors (e.g., single ventricle physiology, prior surgeries) impacting AAD management.
  • Comparison of AAD properties and their suitability for specific ACHD scenarios.

Conclusions:

  • Tailored AAD selection is essential for effective arrhythmia management in ACHD.
  • Understanding ACHD-specific physiology is critical for optimizing AAD therapy.
  • Further research is needed to refine AAD guidelines for the ACHD population.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
355
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
308
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
519
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.4K
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
330
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
581